These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23672630)

  • 1. Cardiovascular risk reduction with combination of anti-atherosclerotic medications in younger and older patients.
    Athyros VG; Katsiki N; Karagiannis A
    Curr Med Res Opin; 2013 Jul; 29(7):791-2. PubMed ID: 23672630
    [No Abstract]   [Full Text] [Related]  

  • 2. Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program).
    Hobbs FD; Gensini G; Mancini GB; Manolis AJ; Bauer B; Böhler S; Genest J; Feldman R; Harvey P; Jenssen TG; Metcalfe M; da Silva PM;
    Int J Cardiol; 2006 Jun; 110(2):242-50. PubMed ID: 16338012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin + amlodipine: new drug. Just a commercial ploy.
    Prescrire Int; 2007 Jun; 16(89):105. PubMed ID: 17582926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study).
    Erdine S; Ro YM; Tse HF; Howes LG; Aguilar-Salinas CA; Chaves H; Guindy R; Chopra P; Moller RA; Schou IM;
    J Hum Hypertens; 2009 Mar; 23(3):196-210. PubMed ID: 18800143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slovak trial on cardiovascular risk reduction following national guidelines with CaDUET® (the STRONG DUET study).
    Fedacko J; Pella D; Jarcuska P; Sabol F; Kmec J; Lopuchovsky T; Merkovska L; Jedlickova L; Janicko M; Sajty M
    Adv Ther; 2013 Jan; 30(1):60-70. PubMed ID: 23328937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous treatment of blood pressure and cholesterol beats the 'SILO' approach in lowering cardiovascular risk: results of the CRUCIAL study.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(2):101. PubMed ID: 21556456
    [No Abstract]   [Full Text] [Related]  

  • 7. Design and rationale of a real-life study to compare treatment strategies for cardiovascular risk factors: the CRUCIAL study.
    Zamorano J; Erdine S; Lopez AP; Kim JH; Al Khadra A; Westergaard M; Sutradhar S; Yunis C;
    Postgrad Med; 2010 Mar; 122(2):7-15. PubMed ID: 20203451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of amlodipine plus atorvastatin association in hypertensive hypercholesterolemic patients.
    Derosa G; Maffioli P
    Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):835-43. PubMed ID: 20528641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin and amlodipine co-treatment in ASCOT--LLA shows benefit.
    Cardiovasc J S Afr; 2007; 18(1):43-4. PubMed ID: 17392998
    [No Abstract]   [Full Text] [Related]  

  • 10. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
    Liew D; Park HJ; Ko SK
    Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, placebo-controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: the respond trial.
    Preston RA; Harvey P; Herfert O; Dykstra G; Jukema JW; Sun F; Gillen D
    J Clin Pharmacol; 2007 Dec; 47(12):1555-69. PubMed ID: 18048574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease.
    Frishman WH; Zuckerman AL
    Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):675-81. PubMed ID: 15350169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin and amlodipine: the successful duet that led to Caduet.
    Cardiovasc J Afr; 2009; 20(1):87-8. PubMed ID: 19287825
    [No Abstract]   [Full Text] [Related]  

  • 14. Atorvastatin calcium plus amlodipine for the treatment of hypertension.
    Delgado-Montero A; Zamorano JL
    Expert Opin Pharmacother; 2012 Dec; 13(18):2673-85. PubMed ID: 23140185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Considerable LDL lowering is advantageous].
    MMW Fortschr Med; 2005 Sep; 147(35-36):9. PubMed ID: 16180563
    [No Abstract]   [Full Text] [Related]  

  • 16. A closer look at Caduet. The new generation of combination treatment.
    Brock CM; Pitcock J
    Adv Nurse Pract; 2005 Jan; 13(1):31-3. PubMed ID: 15679289
    [No Abstract]   [Full Text] [Related]  

  • 17. Vascular protection of dual therapy (atorvastatin-amlodipine) in hypertensive patients.
    Martín-Ventura JL; Tuñon J; Duran MC; Blanco-Colio LM; Vivanco F; Egido J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S189-93. PubMed ID: 17130260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too].
    MMW Fortschr Med; 2005 Aug; 147(33-34):51. PubMed ID: 16138641
    [No Abstract]   [Full Text] [Related]  

  • 19. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
    Robinson JG; Ballantyne CM; Hsueh W; Rosen J; Lin J; Shah A; Lowe RS; Hanson ME; Tershakovec AM
    J Clin Lipidol; 2011; 5(6):474-82. PubMed ID: 22108151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study suggests statins for diabetics with healthy LDL cholesterol levels.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Sep; 15(18):1-2, 6-7. PubMed ID: 15452942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.